BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23429819)

  • 21. Comorbid Premenstrual Dysphoric Disorder and Bipolar Disorder: A Review.
    Slyepchenko A; Minuzzi L; Frey BN
    Front Psychiatry; 2021; 12():719241. PubMed ID: 34512419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).
    Halbreich U; Borenstein J; Pearlstein T; Kahn LS
    Psychoneuroendocrinology; 2003 Aug; 28 Suppl 3():1-23. PubMed ID: 12892987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample.
    Tschudin S; Bertea PC; Zemp E
    Arch Womens Ment Health; 2010 Dec; 13(6):485-94. PubMed ID: 20449618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Premenstrual syndrome and premenstrual dysphoric disorders among Jordanian women.
    Albsoul-Younes A; Alefishat E; Farha RA; Tashman L; Hijjih E; AlKhatib R
    Perspect Psychiatr Care; 2018 Jul; 54(3):348-353. PubMed ID: 29215138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suicidal Risk in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Systematic Review and Meta-Analysis.
    Prasad D; Wollenhaupt-Aguiar B; Kidd KN; de Azevedo Cardoso T; Frey BN
    J Womens Health (Larchmt); 2021 Dec; 30(12):1693-1707. PubMed ID: 34415776
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder among college students of Bhavnagar, Gujarat.
    Raval CM; Panchal BN; Tiwari DS; Vala AU; Bhatt RB
    Indian J Psychiatry; 2016; 58(2):164-70. PubMed ID: 27385849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Premenstrual dysphoric disorder: diagnosis and therapeutic strategy].
    Bianchi-Demicheli F
    Rev Med Suisse; 2006 Feb; 2(52):393-4, 397-9. PubMed ID: 16523546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain Structure and Function in Women with Comorbid Bipolar and Premenstrual Dysphoric Disorder.
    Syan SK; Minuzzi L; Smith M; Costescu D; Allega OR; Hall GBC; Frey BN
    Front Psychiatry; 2017; 8():301. PubMed ID: 29367847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A lack of consistent evidence for cortisol dysregulation in premenstrual syndrome/premenstrual dysphoric disorder.
    Kiesner J; Granger DA
    Psychoneuroendocrinology; 2016 Mar; 65():149-64. PubMed ID: 26789492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China.
    Qiao M; Zhang H; Liu H; Luo S; Wang T; Zhang J; Ji L
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):83-6. PubMed ID: 22377229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Premenstrual symptoms and posttraumatic stress disorder in Japanese high school students 9 months after the great East-Japan earthquake.
    Takeda T; Tadakawa M; Koga S; Nagase S; Yaegashi N
    Tohoku J Exp Med; 2013 Jul; 230(3):151-4. PubMed ID: 23842447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression, irritability, and anxiety in women with premenstrual dysphoric disorder.
    Ko CH; Long CY; Chen SY; Chen IJ; Huang TH; Yen JY
    Int J Psychiatry Med; 2013; 46(1):39-55. PubMed ID: 24547609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Premenstrual dysphoric disorder and sexual function: a narrative review.
    Susser LC; Parish S; Dumas E; Nappi RE
    Sex Med Rev; 2023 Jun; 11(3):202-211. PubMed ID: 36941212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.
    Girdler SS; Straneva PA; Light KC; Pedersen CA; Morrow AL
    Biol Psychiatry; 2001 May; 49(9):788-97. PubMed ID: 11331087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Prevalence of Menstrual Cycle Disorders and Menstrual Cycle-Related Symptoms in Female Athletes: A Systematic Literature Review.
    Taim BC; Ó Catháin C; Renard M; Elliott-Sale KJ; Madigan S; Ní Chéilleachair N
    Sports Med; 2023 Oct; 53(10):1963-1984. PubMed ID: 37389782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in symptom scores and health outcomes in premenstrual syndrome.
    Borenstein JE; Dean BB; Leifke E; Korner P; Yonkers KA
    J Womens Health (Larchmt); 2007 Oct; 16(8):1139-44. PubMed ID: 17937566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review.
    Cerqueira RO; Frey BN; Leclerc E; Brietzke E
    Arch Womens Ment Health; 2017 Dec; 20(6):713-719. PubMed ID: 29063202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobacco consumption and premenstrual syndrome: A case-control study.
    Fernández MDM; Montes-Martínez A; Piñeiro-Lamas M; Regueira-Méndez C; Takkouche B
    PLoS One; 2019; 14(6):e0218794. PubMed ID: 31226148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depressive mood and frontal alpha asymmetry during the luteal phase in premenstrual dysphoric disorder.
    Lin IM; Tsai YC; Peper E; Yen CF
    J Obstet Gynaecol Res; 2013 May; 39(5):998-1006. PubMed ID: 23551544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
    Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
    Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.